Ledger.Open graph →
SEC Form D · Amendment · filed August 24, 2021

Blue Note Therapeutics, Inc

Offering
$50.0M
Sold
$15.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Andrew Firlik · SAN FRANCISCO, CADirectorJohn Harris · SAN FRANCISCO, CADirectorGeoffrey Eich · SAN FRANCISCO, CAExec · DirectorMatthew H. Wosk · Newton, MADirectorThomas Spencer · Mendota Heights, MNExec · DirectorYoun-Long Lin · Hsinchu County, F5DirectorLaurence Bastien · San Antonio, TXExec · DirectorMichael J. Boyd · San Antonio, TXDirectorJason Hans · San Antonio, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗